NMT Technology for Neuromuscular Monitoring
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines a new technology called neuromuscular monitoring technology (NMT), which assists doctors in monitoring muscle response during surgeries involving paralytic drugs. The trial aims to gather feedback from medical professionals on the device's performance and to collect data from it. Suitable candidates for this trial include those undergoing procedures requiring paralytic medication and who can have a sensor placed on their hand or forearm. Individuals with tattoos, scars, or conditions on their arm that might interfere with the sensor may not be suitable for this trial.
As an unphased trial, this study offers participants the chance to contribute to the development of innovative medical technology.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, since it involves procedures requiring paralytic medication, it's best to discuss your current medications with the trial team.
What prior data suggests that this NMT Technology is safe for neuromuscular monitoring?
Research shows that using NMT Technology to check muscle function can make surgeries safer. Studies have found that this technology provides accurate readings of muscle activity during surgery, helping doctors monitor and adjust treatment as needed.
NMT monitoring also enhances anesthesia safety by offering ongoing, clear information that helps predict when a patient will wake from anesthesia. This timely data can smooth recovery and may reduce complications.
Although specific studies do not provide detailed safety data, the use of NMT Technology in hospitals suggests it is generally safe. However, like any treatment, rare side effects or risks may occur, so discussing this with a doctor is advisable.1234Why are researchers excited about this trial?
Researchers are excited about NMT Technology for neuromuscular monitoring because it offers a new approach to tracking muscle function during surgeries. Unlike traditional methods that often involve more invasive procedures or rely on indirect measurements, NMT Technology uses a sensor directly placed on the patient, providing real-time feedback. This method can potentially enhance surgical precision and patient safety by offering more accurate and immediate monitoring of neuromuscular responses.
What evidence suggests that this NMT Technology is effective for neuromuscular monitoring?
Research has shown that NMT Technology, used to monitor muscles, reduces the need for muscle-relaxing drugs during surgery and lowers the risk of lasting muscle weakness afterward. Studies indicate that this technology offers more stable and accurate readings, preventing errors. Precise monitoring ensures proper muscle recovery after relaxation during surgery, avoiding complications upon waking. These findings suggest that NMT Technology effectively ensures a safe recovery from muscle relaxation during and after medical procedures.3567
Are You a Good Fit for This Trial?
This trial is for adults (18+) who need muscle relaxant drugs during a medical procedure and can give written consent. They'll have their muscle function monitored with an NMT ElectroSensor on the hand/forearm.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Placement of NMT Sensor and collection of feedback during standard of care surgical procedure
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- NMT Technology
Trial Overview
The study is testing the NMT EasyFit Sensor and Cable technology, which monitors neuromuscular function in patients receiving paralytic medication during procedures.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Placement of NMT Sensor
Find a Clinic Near You
Who Is Running the Clinical Trial?
GE Healthcare
Lead Sponsor
Fotis Vlachos
GE Healthcare
Chief Marketing Officer since 2024
PhD in Molecular Biology and Biochemistry from the University of Massachusetts, MBA from the Wharton School of the University of Pennsylvania
Peter J. Arduini
GE Healthcare
Chief Executive Officer since 2022
MBA from Northwestern University, BSc in Marketing from Susquehanna University
Loma Linda University
Collaborator
Citations
1.
clinicalview.gehealthcare.com
clinicalview.gehealthcare.com/article/research-practice-advancements-nmt-train-four-monitoringAdvancements in NMT with train of four monitoring
The study authors concluded that the dose of NMBDs and incidence of residual paralysis decreases with NMT monitoring, and the use of reversal ...
electromyography-based neuromuscular monitoring in ... - PMC
EMG-based monitoring is associated with reduced calibration time, improved stability against signal drift, and superior prevention of residual ...
Advancements in Quantitative Neuromuscular Monitoring
Quantitative neuromuscular monitoring is the only reliable means of confirming adequate recovery from neuromuscular blockade and avoiding postoperative ...
4.
xavant.com
xavant.com/quantitative-neuromuscular-monitoring-in-the-operating-room-pacu-and-icu-amg-vs-emg/Quantitative Neuromuscular Monitoring in the Operating ...
The Stimpod NMS450X enables you to leverage the power of both AMG and EMG for reliable and accurate quantitative NMT monitoring at your facility.
5.
apsf.org
apsf.org/article/patient-safety-and-quantitative-neuromuscular-transmission-monitoring-in-2022/Patient Safety and Quantitative Neuromuscular ...
The recommendation for NMT monitoring arises from accumulated experiences of residual neuromuscular blockade in postoperative patients, which is not a rare ...
6.
clinicalview.gehealthcare.com
clinicalview.gehealthcare.com/article/how-quantitative-neuromuscular-monitoring-advancing-anesthesia-safetyHow quantitative neuromuscular monitor is advancing ...
Quantitative NMT monitoring enhances anesthesia safety by providing quantifiable data. These continuous, objective measurements of muscle ...
7.
clinicalview.gehealthcare.com
clinicalview.gehealthcare.com/quick-guide/nmt-helping-enhance-anesthesia-safety-and-recovery-quantitative-nmt-monitoringNMT: Helping to Optimize Recovery from Anesthesia
Monitoring the level of neuromuscular block enables follow-up and prediction of recovery and helps in correct timing of the antagonists, which may decrease the ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.